文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

腹部与盆腔大手术后延长与常规血栓预防:随机临床试验系统综述与荟萃分析

Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials.
PubMed 文献 · Surgery · 2018-09-03

该系统综述与荟萃分析纳入4项随机对照试验,比较腹部与盆腔大手术后延长(4周)与常规(1周)低分子肝素血栓预防。延长预防降低了术后静脉血栓栓塞、深静脉血栓及近端深静脉血栓发生率,未增加术后出血;预防静脉血栓栓塞、总体深静脉血栓及近端深静脉血栓的需治疗人数分别为14、14和44。术后症状性肺栓塞罕见且两组发生率相似。

要点

  • 延长低分子肝素预防降低腹部盆腔术后静脉血栓栓塞和深静脉血栓
  • 延长预防未增加术后出血,症状性肺栓塞两组相似
  • 预防静脉血栓栓塞和深静脉血栓的NNT均为14,近端深静脉血栓为44

核心结论

  • 延长低分子肝素预防与无症状静脉血栓栓塞减少相关。
  • 因肺栓塞总体发生率低,其对肺栓塞影响的证据仍稀疏。
  • 延长预防应考虑用于高风险患者。

研究设计与样本

  • 研究为随机对照试验的系统综述与荟萃分析。
  • 检索MEDLINE数据库(PubMed、EMBASE、Web of Science)电子系统搜索。
  • 比较术后延长(4周)与常规(1周)低分子肝素预防。
  • 共4项随机对照试验符合预设标准。

主要发现

  • 延长低分子肝素预防降低术后静脉血栓栓塞发生率。
  • 延长预防降低术后深静脉血栓发生率。
  • 延长预防降低术后近端深静脉血栓发生率。
  • 延长预防未增加术后出血。
  • 术后症状性肺栓塞罕见且两组发生率相似。

关键数值与推荐

  • 预防静脉血栓栓塞的需治疗人数为14。
  • 预防总体深静脉血栓的需治疗人数为14。
  • 预防近端深静脉血栓的需治疗人数为44。
  • 延长预防疗程为4周,常规预防疗程为1周。

临床怎么用

  • 腹部与盆腔大手术后可考虑延长低分子肝素预防至4周。
  • 延长预防应优先考虑高风险患者。
  • 延长预防未增加术后出血,但需结合患者出血风险评估。

局限性

  • 仅纳入4项随机对照试验,证据基础有限。
  • 肺栓塞总体发生率低,对其影响证据稀疏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism, presenting as deep vein thrombosis or pulmonary embolism, can be associated with considerable morbidity after major abdominal and pelvic surgery. Perioperative thromboprophylaxis with low-molecular-weight heparin is well established, but the duration of treatment remains debated. We aimed to assess the efficacy and safety of extended (4-week) versus conventional (1-week) thromboprophylaxis with low-molecular-weight heparin in patients undergoing abdominopelvic surgery. METHODS: Using MEDLINE databases (PubMed, EMBASE, and Web of Science), we conducted an electronic, systematic search of randomized controlled trials comparing post-operative extended versus conventional low-molecular-weight heparin on venous thromboembolism, deep vein thrombosis, and pulmonary embolism rates. RESULTS: Four randomized controlled trials met the predefined criteria. Extended prophylaxis with low-molecular-weight heparin after major abdominal and pelvic surgery decreased rates of postoperative venous thromboembolism, deep vein thrombosis, and proximal deep vein thrombosis without increased postoperative bleeding. Numbers needed to treat to prevent venous thromboembolism, overall deep vein thrombosis, and proximal deep vein thrombosis were 14, 14, and 44, respectively. Rates of postoperative symptomatic PE were rare, and the incidence was similar in both groups. CONCLUSION: Extended prophylaxis with low-molecular-weight heparin is associated with a decrease in asymptomatic venous thromboembolism. There remains sparse evidence regarding its impact on pulmonary embolism because of the overall low incidence. Extended prophylaxis should be considered in high-risk patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Rausa E, Kelly ME, Asti E, et al. Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials. Surgery. 2018. PMID: 30190110. doi:10.1016/j.surg.2018.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。